Downloadable Slidesets

Share

Program Content

Activities

  • Unresectable Stage III NSCLC
    Optimal Treatment of Unresectable, Stage III NSCLC
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 31, 2019

    Expires: May 29, 2020

  • First-line <i>EGFR</i>-Positive NSCLC
    First-line Treatment of EGFR Mutation–Positive NSCLC
    Case Challenge
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 31, 2019

    Expires: May 29, 2020

  • <i>ALK</i>-Positive NSCLC
    Treatment of ALK Translocation–Positive NSCLC
    Case Challenge
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 31, 2019

    Expires: May 29, 2020

  • First-line Immunotherapy in NSCLC
    Optimal Use of First-line Immunotherapy in the Treatment of Advanced NSCLC
    Case Challenge
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 31, 2019

    Expires: May 29, 2020

Faculty

cover img faculity

Heather J. Jackson, PhD, FNP-BC, NEA-BC, FAANP

Associate Professor
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University School of Nursing
Administrative Director of Advanced Practice
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

cover img faculity

Edward S. Kim, MD

Chief, Section of Head and Neck Medical Oncology
Associate Professor, Thoracic/Head and Neck Medical Oncology
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Zofia Piotrowska, MD

Assistant Professor of Medicine
Massachusetts General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts

cover img faculity

Suresh S. Ramalingam, MD

Associate Professor
Director,
Division of Medical Oncology
Emory University, Winship Cancer Institute
Atlanta, Georgia

cover img faculity

H. Jack West, MD

Medical Director
Thoracic Oncology Program
Swedish Cancer Institute
Seattle, Washington

Provided by

ProCE Banner

Supporters

AstraZeneca